evaluation of the effects of Ascorbic acid on attenuation of the statin induced myopathy
Phase 3
Recruiting
- Conditions
- Myopathy.Drug-induced myopathyG72.0
- Registration Number
- IRCT20191106045356N2
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
People between 80-30 years old
Patients undergoing exercise for cardiac rehabilitation
Daily intake of 40 mg of atorvastatin
Maximum weight 80 kg
Non-pregnancy of women
The patient should not have severe peptic ulcer
Exclusion Criteria
Vitamin C intolerance
Do not take medication for more than two consecutive days
Do not take atorvastatin for more than two consecutive days
The patient becomes pregnant
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method